Vivos Therapeuticsinc Stock Market Value
| VVOS Stock | USD 2.66 0.04 1.48% |
| Symbol | Vivos |
Vivos TherapeuticsInc Price To Book Ratio
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vivos TherapeuticsInc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vivos TherapeuticsInc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vivos TherapeuticsInc.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Vivos TherapeuticsInc on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Vivos TherapeuticsInc or generate 0.0% return on investment in Vivos TherapeuticsInc over 30 days. Vivos TherapeuticsInc is related to or competes with Agilent Technologies, Illumina, Waters, Thermo Fisher, Mettler Toledo, Charles River, and Guardant Health. Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients ... More
Vivos TherapeuticsInc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vivos TherapeuticsInc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vivos TherapeuticsInc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 52.45 | |||
| Value At Risk | (10.79) | |||
| Potential Upside | 7.85 |
Vivos TherapeuticsInc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vivos TherapeuticsInc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vivos TherapeuticsInc's standard deviation. In reality, there are many statistical measures that can use Vivos TherapeuticsInc historical prices to predict the future Vivos TherapeuticsInc's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.31) | |||
| Total Risk Alpha | (1.91) | |||
| Treynor Ratio | (1.01) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vivos TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vivos TherapeuticsInc Backtested Returns
Vivos TherapeuticsInc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.18, which indicates the firm had a -0.18% return per unit of risk over the last 3 months. Vivos TherapeuticsInc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vivos TherapeuticsInc's Coefficient Of Variation of (578.40), variance of 50.41, and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide. The entity has a beta of 1.23, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vivos TherapeuticsInc will likely underperform. Vivos TherapeuticsInc has an expected return of -1.26%. Please make sure to validate Vivos TherapeuticsInc potential upside and day median price , to decide if Vivos TherapeuticsInc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.52 |
Modest predictability
Vivos TherapeuticsInc has modest predictability. Overlapping area represents the amount of predictability between Vivos TherapeuticsInc time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vivos TherapeuticsInc price movement. The serial correlation of 0.52 indicates that about 52.0% of current Vivos TherapeuticsInc price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Vivos TherapeuticsInc lagged returns against current returns
Autocorrelation, which is Vivos TherapeuticsInc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vivos TherapeuticsInc's stock expected returns. We can calculate the autocorrelation of Vivos TherapeuticsInc returns to help us make a trade decision. For example, suppose you find that Vivos TherapeuticsInc has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vivos TherapeuticsInc regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vivos TherapeuticsInc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vivos TherapeuticsInc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vivos TherapeuticsInc stock over time.
Current vs Lagged Prices |
| Timeline |
Vivos TherapeuticsInc Lagged Returns
When evaluating Vivos TherapeuticsInc's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vivos TherapeuticsInc stock have on its future price. Vivos TherapeuticsInc autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vivos TherapeuticsInc autocorrelation shows the relationship between Vivos TherapeuticsInc stock current value and its past values and can show if there is a momentum factor associated with investing in Vivos TherapeuticsInc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vivos TherapeuticsInc is a strong investment it is important to analyze Vivos TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vivos TherapeuticsInc's future performance. For an informed investment choice regarding Vivos Stock, refer to the following important reports:Check out Vivos TherapeuticsInc Correlation, Vivos TherapeuticsInc Volatility and Vivos TherapeuticsInc Alpha and Beta module to complement your research on Vivos TherapeuticsInc. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Vivos TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.